Evidence map›Paper›PMID 26193474›Full record

ArticlePloS one2015

The Ages and Stages Questionnaire and Neurodevelopmental Impairment in Two-Year-Old Preterm-Born Children.

Jorien M Kerstjens, Ard Nijhuis, Christian V Hulzebos, Deirdre E van Imhoff, Aleid G van Wassenaer-Leemhuis, Ingrid C van Haastert, Enrico Lopriore, Titia Katgert, Renate M Swarte, Richard A van Lingen and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02621645 (Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02621645 phase4unknown statusnot on this mapstarted 2016, after this paper: background citation

Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence: an Open-label Randomized Controlled Trial: TRAPIST - TRAP Intervention STudy

TypeinterventionalSponsorUniversitaire Ziekenhuizen KU LeuvenRan2016 to 2025Enrolled126ConditionsTwin Reversal Arterial Perfusion SyndromeArmsEarly selective reduction of TRAP mass, Late selective reduction of TRAP mass, Ultrasound-guided intrafetal ablation using a 18 to 20 Gauge needle, Ultrasound-guided intrafetal ablation using a 17 to 20 Gauge needle, Laser coagulation of the cord or anastomising vessels through a 17 Gauge to 7 French trocar, with a 1-1,3 mm fetoscope and a 400 µm laser fiber
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. "STEP", an early developmental screening tool that predicts one-year outcomes.Journal of perinatology : official journal of the California Perinatal Association · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jorien M KerstjensDivision of Neonatology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.
Ard NijhuisDivision of Neonatology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.
Christian V HulzebosDivision of Neonatology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.
Deirdre E van ImhoffDivision of Neonatology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.
Aleid G van Wassenaer-LeemhuisDepartment of Neonatology, Emma Children's Hospital Academic Medical Center, Amsterdam, The Netherlands.
Ingrid C van HaastertDepartment of Neonatology, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Enrico LoprioreDivision of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
Titia KatgertDepartment of Medical Psychology, Máxima Medical Center, Veldhoven, The Netherlands.
Renate M SwarteDepartment of Neonatology, Erasmus MC-Sophia, Rotterdam, The Netherlands.
Richard A van LingenPrincess Amalia Department of Pediatrics, Department of Neonatology, Isala, Zwolle, The Netherlands.
Twan L MulderDepartment of Pediatrics, Maastricht University Medical Center, GROW-School for Oncology and Developmental Biology, Maastricht, The Netherlands.
Céleste R LaarmanDivision of Neonatology, Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands.
Katerina SteinerDivision of Neonatology, Department of Pediatrics, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands.
Peter H DijkDivision of Neonatology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo test the ability of the Ages and Stages Questionnaire, Third Edition (ASQ3) to help identify or exclude neurodevelopmental impairment (NDI) in very preterm-born children at the corrected age of two.

methodsWe studied the test results of 224 children, born at <32 postmenstrual weeks, who had scores on ASQ3 and Bayley Scales of Infant and Toddler Development, Third Edition (BSIDIII) and neurological examination at 22-26 months' corrected age. We defined NDI as a score of <70 on the cognitive--or motor composite scale of BSIDIII, or impairment on neurological examination or audiovisual screening. We compared NDI with abnormal ASQ3 scores, i.e., < -2SDs on any domain, and with ASQ3 total scores. To correct for possible overestimation of BSIDIII, we also analyzed the adjusted BSIDIII thresholds for NDI, i.e., scores <80 and <85.

resultsWe found 61 (27%) children with abnormal ASQ3 scores, and 10 (4.5%) children who had NDI with original BSIDIII thresholds (<70). Twelve children had NDI at BSIDIII thresholds at <80, and 15 had <85. None of the 163 (73%) children who passed ASQ3 had NDI. The sensitivity of ASQ3 to detect NDI was excellent (100%), its specificity was acceptable (76%), and its negative predictive value (NPV) was 100%. Sensitivity and NPV remained high with the adjusted BSIDIII thresholds.

conclusionThe Ages and Stages Questionnaire is a simple, valid and cost-effective screening tool to help identify and exclude NDI in very preterm-born children at the corrected age of two years.

Indexed as

Neurologic ExaminationArea Under CurveBirth WeightChild DevelopmentChild, PreschoolDevelopmental DisabilitiesFemaleGestational AgeHumansInfantInfant, PrematureMaleNeuronsROC CurveSurveys and Questionnaires

Identifiers

PMID26193474
PMCPMC4508030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.